Novartis Croatia Ltd. is part of the Swiss multinational pharmaceutical company Novartis AG with headquarters in Basel. Novartis is ranked as one of the world's top five companies overall and is one of the largest pharmaceutical companies in the world. The history of the company dates back to the 18th century, and in 1996, the merger of Ciba-Geigy and Sandoz created a company under the common name Novartis. The name comes from the Latin 'Novae Artes', which means 'new skills', which gave a seal to the mission and vision of Novartis - a commitment to scientific research and development in order to provide the world's wide population with new, innovative medicines and a longer, healthier and better life, regardless of where they live. In 2023 alone. Novartis has impacted the lives of 277.7 million patients in 144 markets. Today, Novartis is a pioneer in early scientific research, recognized for its groundbreaking results of studies that are changing medical practice, and has positioned itself as a synonym for transformative medicine. It is committed to collaborating with academic institutions and pushing the boundaries of science, emphasizing the importance of sustainability and creating long-term value for patients, shareholders, employees, and society as a whole. Novartis combines groundbreaking science with digital technologies, striving for a world where diseases can be prevented, accurately diagnosed and effectively cured, and focuses on five therapeutic areas: cardiovascular disease, immunology, neuroscience, solid tumors and hematology.